Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Fidelity

Pharmaceuticals Portfolio (FPHAX)

Ticker FPHAX · · Holdings as of May 31, 2026

Expense ratio
0.67%$67/yr per $10k
5-yr return
+12.6%annualized
1-yr return
+30.3%as of Apr 2026
Net assets
$1.5Ball share classes
Holdings
57

Bottom line

Is FPHAX a good fund? The bottom line

FPHAX is an actively managed health care sector mutual fund from Fidelity.

It charges 0.67% — about $67 a year on every $10,000 invested, cheaper than 72% of health care sector funds we track.

It returned +30.3% over one year, +12.6% a year over five years, +10.0% a year over ten (as of Apr 30, 2026, per its prospectus).

With $1.5 billion in net assets and 57 holdings, its largest position is ELI LILLY and CO (28.8%) and the top 10 make up 73.8% of the portfolio.

What stands out

  • 5-year return beat 98% of category peers

What to watch

  • Concentrated: top 10 holdings are 73.8% of assets

Updated Nov 19, 2026

What FPHAX invests in

Pharmaceuticals Portfolio seeks capital appreciation.

Normally investing at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. These companies may include, for example, pharmaceutical companies and other companies involved in the research, development, manufacture, sale, or distribution of drugs, including companies that facilitate the testing or regulatory approval of drugs, including veterinary drugs. For purposes of the fund's policy to normally invest at least 80% of its assets in securities of companies principally engaged in the business activity or activities identified for the fund, Fidelity may consider a company to be principally engaged in the designated business activity or activities based on: (i) the level of a company's assets, income, sales, or profits that are committed to, derived from, or related to the designated business…

From the fund's prospectus (filed Apr 24, 2026).

FPHAX performance

Fund calendar-year total returns, 2016–2025 2016: −16.3%; 2017: +10.7%; 2018: +5.8%; 2019: +31.6%; 2020: +11.1%; 2021: +11.8%; 2022: +1.0%; 2023: +12.5%; 2024: +9.4%; 2025: +30.3% −16% 2016 +11% 2017 +6% 2018 +32% 2019 +11% 2020 +12% 2021 +1% 2022 +13% 2023 +9% 2024 +30% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
FPHAX+30.3%+12.6%+10.0%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Apr 30, 2026

Full FPHAX performance history →

What FPHAX costs

On a $10,000 investment, FPHAX's 0.67% expense ratio costs about $67 a year. The prospectus estimates $835 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full FPHAX fee table →

FPHAX top 10 holdings

#Holding% of fund
1ELI LILLY and CO28.78%
2Gsk Plc8.17%
3Viatris Inc5.45%
4Ucb Sa5.09%
5MERCK and CO INC4.74%
6Roche Holding Ag4.54%
7Legend Biotech Corp4.53%
8Astrazeneca Plc4.22%
9Elanco Animal Health Inc4.15%
10Jazz Pharmaceuticals Plc4.09%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 73.8% of the fund. See all top 25 holdings and asset mix →

Alternatives to FPHAX

More funds like FPHAX →

FPHAX FAQ

What is the expense ratio of FPHAX?
FPHAX's expense ratio is 0.67%, which works out to about $67 a year for every $10,000 invested. The prospectus estimates total costs of $835 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is FPHAX a good investment?
It depends on your goals, but the data points to: 5-year return beat 98% of category peers; concentrated: top 10 holdings are 73.8% of assets. This is general information, not personalized advice.
What does FPHAX hold?
FPHAX's largest holdings are ELI LILLY and CO (28.8%), Gsk Plc (8.2%), Viatris Inc (5.5%), Ucb Sa (5.1%), MERCK and CO INC (4.7%). It holds 57 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is FPHAX's 5-year return?
FPHAX returned +12.6% a year over the five years ending Apr 30, 2026, and +10.0% a year over ten years. Past performance does not guarantee future results.
Who manages FPHAX?
FPHAX is offered by Fidelity through Fidelity Select Portfolios.